000			02305nam a22003858i 4500
001			43927
003			BD-DhAAL
005			20250105125323.0
008			250105t2021 njua b 001 0 eng d
010			_a 2021001628
020			_a9781119821472
020			_a9781119530305
040			_aDLC _beng _erda _cDLC _dDLC _dBD-DhAAL
042			_apcc
050	0	0	_aRS403 _b.B8 2021
082	0	0	_a615.19 _223
245	0	0	_aBurger's medicinal chemistry, drug discovery and development. _nVolume 4 / _ceditor-in-chief, Donald J. Abraham ; consulting editor, Michael Myers.
250			_aEighth edition / _beditor-in-chief Donald J. Abraham, Virginia Commonwealth University ; consulting editor Michael Myers, Eli Lilly & Company.
260			_aHoboken, NJ : _bWiley, _cc2021.
300			_axvii, 542 pages : _bcolor illustrations ; _c26 cm
362			_aVol. 4
500			_aRevision of: Burger's medicinal chemistry and drug discovery. 6th ed. / edited by Donald J. Abraham. c2003.
504			_aIncludes bibliographical references and index.
505	0		_avolume 4. Cardiovascular, endocrine and metabolic diseases / volume editor, Scott D. Edmondson
520			_a"Burger's is a flagship reference source for medicinal chemists and pharmaceutical professionals. This updated and expanded 8th edition has been thoroughly revised and improved to incorporate the concepts of drug hunting along with its existing coverage of the entire process of drug discovery and development. Bringing in a new and expert editorial board, this new edition updates existing chapters and adds 35 new ones, with topics including: opioid addiction treatments, antibody and gene therapy for cancer, blood-brain barrier, HIV treatments, and industrial-academic collaboration structures"--
526			_aPHR
650		0	_aPharmaceutical chemistry.
650		0	_aDrug development.
650		0	_aPharmacy.
700	1		_aAbraham, Donald J., _d1936- _eeditor.
730	0		_aBurger's medicinal chemistry and drug discovery. _957401
852			_aAyesha Abed Library _cReference Section
942			_2ddc _cBK
999			_c46896 _d46896